Iowanews Headlines

The Europe In Vitro Diagnostics (IVD) Market is set for sustained expansion, reflecting the growing clinical reliance on laboratory-based and point-of-care diagnostic solutions across the region.

The market is projected to grow from USD 33.83 billion in 2026 to USD 49.49 billion by 2031, registering a CAGR of 7.9% during the forecast period.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20552722

Market Growth Drivers

The Europe IVD market is expanding rapidly due to:

• Rising prevalence of chronic diseases such as diabetes and cardiovascular disorders

• Increasing incidence of infectious diseases requiring routine screening

• Growth in preventive healthcare and early disease detection programs

• Technological advancements in molecular diagnostics and next-generation sequencing

• Expansion and modernization of laboratory infrastructure across public health systems

Advances in laboratory automation, high-throughput systems, and point-of-care testing are enabling faster, more accurate, and more accessible diagnostic services. At the same time, broader diagnostic coverage within European healthcare systems is sustaining high testing volumes and supporting long-term market growth.

Reagents & Kits Segment Dominated in 2025

By product & service, the reagents & kits segment accounted for the largest share of the European IVD market in 2025.

The in vitro diagnostics market in Europe is divided by product & service into reagents & kits, instruments, and data management software & services. Of these, the reagents & kits segment represents the largest market since these products are in constant demand across routine and specialized diagnostic testing, such as immunoassays, molecular diagnostics, clinical chemistry, and others.

Because reagents and kits are required for each test performed, their recurring demand ensures stable revenue streams and sustained segment leadership.

Immunoassay Led by Technology in 2025

By technology, immunoassay held the largest share of the Europe IVD market in 2025.

The in vitro diagnostics market in Europe is divided into immunoassay, clinical chemistry, molecular diagnostics, glucose monitoring, hematology, microbiology, coagulation & hemostasis, blood gas analyzers, urinalysis, and chromatography & mass spectrometry.

Their compatibility with automated laboratory platforms, high throughput capabilities, and expanding assay menus have reinforced their widespread adoption across healthcare settings in Europe. Continued innovation in assay sensitivity and multiplex testing is further strengthening this segment.

Request For Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=20552722

Competitive Landscape

The Europe IVD market features a strong presence of global diagnostic leaders, including: F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), Siemens Healthineers AG (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), bioMérieux (France), Sysmex Corporation (Japan), Becton, Dickinson and Company (US), Werfen (Spain), and Illumina, Inc. (US)

Conclusion

The Europe In Vitro Diagnostics market is positioned for consistent growth through 2031, supported by rising disease burden, expanding screening initiatives, and continuous technological advancement. With strong demand for reagents and immunoassay-based testing, alongside modernization of laboratory infrastructure, IVD remains a cornerstone of Europe’s evolving healthcare ecosystem.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/europe-in-vitro-diagnostics-market-20552722.html